It has been called into question by Sattar et al. (8, ) in a prospective study and meta-analysis, which revealed lower odds of CAD in patients with lower APN levels (OR=0.89, 95%CI=0.67–1.18). The gene discussed is ANPEP; the disease is coronary artery disorder.